I'm confused. If they have spoken with the FDA already about moving forward with the phase 2/3 trial I would imagine that they could be ready to go in a matter of months. What is wrong with this picture? Maybe they are awaiting fast track designation and that will come shortly. I don't think this will take all year to get started.
Market Data 
Markets 
AI
